References
- Minkoff H, Xian LS, Watts H et al. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women. Obstet. Gynecol.108(4), 953–960 (2006).
- de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology324, 17–27 (2004).
- Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol.189, 12–19 (1999).
- Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer80, 827–841 (1999).
- Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med.338, 423–428 (1998).
- Munoz N, Franceschi S, Bosetti C et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet359, 1093–1101 (2002).
- Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int. J. Cancer117, 1007–1012 (2005).
- Hernandez-Giron C, Smith JS, Lorincz A, Lazcano E, Hernandes-Avila M, Salmeron J. High risk human papillomavirus detection and related risk factors among pregnant and non pregnant women in Mexico. Sex. Transm. Dis.32, 613–618 (2005).
- Castellsague X, Munoz N. Cofactors in human papillomavirus carcinogenesis – role of parity, oral contraception and tobacco smoking. J. Natl Cancer Inst. Monogr.31, 20–28 (2003).
- Chan PK, Chang AR, Tam WH, Cheung JL, Cheng AF. Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant and non pregnant controls. J. Med. Virol.67, 583–588 (2002).
- Palefsky JM, Gillison ML, Strickler HD. HPV vaccines in immunosuppressed men and women. Vaccine24(Suppl. 3), S140–S146 (2006).
- Strickler HD, Burk RD, Fazzari M et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J. Natl Cancer Inst.97(8), 577–586 (2005).
- Flores R, Papenfuss M, Klimecki WT, Giuliano AR. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int. J. Cancer118(5), 1187–1193 (2006).
- Ho CM, Chien TY, Huang SH, Lee BH, Chang SF. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict the risk of cervical cancer. Gynecol. Oncol.102, 54–60 (2006).
- La Ruche G, You B, Mensah-Ado I et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia–neoplasia in African women. Int. J. Cancer76, 480–486 (1998).
- Hawes SE, Critchlow CW, Faye Niang MA et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cancer among African women with human immunodeficiency virus type 1 and 2 infections. J. Infect. Dis.188(4), 555–563 (2003).
- Didelot-Rousseau MN, Nagot N, Costes-Martineau V et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br. J. Cancer95, 355–362 (2006).